Diabetes digital management problems need to be solved urgently, and pharmaceutical companies are actively exploring and trying

 Diabetes, as one of the four chronic diseases that the "Healthy China Action (2019-2030)" focuses on prevention and control, has become an important chronic disease threatening human health
.
According to newly released data from IDF (International Diabetes Federation), the number of diabetic patients in China has exceeded 110 million
.
The huge population of diabetic patients also makes diabetes management an urgent problem in China's medical services
.
It is understood that with the development of digital technologies such as the Internet, big data, and artificial intelligence, digital management of diabetes has become a hot topic
.
Although entering the digital management of diabetes is not an easy path, many pharmaceutical companies are still actively exploring
.
Pharmaceutical companies such as Roche, Eli Lilly, Novo Nordisk, etc.
are still actively trying to find better solutions
.
For example, Roche's layout in the field of diabetes digital management includes acquisitions and localized cooperation
.
Among them, in the localized cooperation, Roche Diagnostics worked closely with the domestic innovative company Jingli Technology to create a full-course active management model for out-of-hospital diabetic patients based on the enterprise WeChat ecosystem, and achieved low-cost and high-cost management of out-of-hospital 20,000+ diabetic patients.
Efficient, large-scale management
.
In the digital management of diabetes, Eli Lilly attaches great importance to the digital collaboration and integration of internal and external processes, and is also strengthening cooperation with resources in various fields of medical care
.
For example, Eli Lilly’s IT team has developed a WeChat-based one-stop doctor service platform "Li Yi" to facilitate communication, interaction with doctors, and provide services
.
Novo Nordisk attaches great importance to the combination of software and hardware
.
On the hardware, it launched the smart insulin pen Nuohe pen, which was updated to the sixth generation this year; on the software, it launched the "Novo Care" applet, a platform for patient education, and jointly launched a Microsoft-based ( Asia) The intelligent dialogue engine developed by the Internet Engineering Institute, and the "Xiao Nuo teacher" who provides text and voice support through the cognitive service of Microsoft's intelligent cloud Azure
.
It is understood that the current diabetes digital management platform has a comprehensive product supply capability, not only can provide conventional products such as blood glucose meters, insulin pens, and oral drugs, but also products that are relatively difficult to store such as insulin can also be supplied on some platforms
.
Online diagnosis and treatment, online drug purchase and offline distribution are gradually being integrated, forming a one-stop digital diabetes management solution
.
The effectiveness, convenience, and individualization of the digital management of diabetes have improved the user's stickiness to the digital management
.
In recent years, in terms of digital diabetes management, companies have continued to deploy and have achieved certain results
.
For another example, on November 14, the H2H blood glucose management project innovatively developed by Fangzhou Jike was officially launched
.
Different from other diabetes management models, Fangzhou Jike’s H2H blood glucose management project advocates uniting diabetes management ecosystems such as diabetes pharmaceutical companies, field experts, and association teams to jointly build an "Internet + diabetes management" ecological cooperation circle to provide blood glucose monitoring, Services including big data analysis, remote follow-up consultations, drug services, daily diet, medication reminders, and health science popularization
.
In addition, the author was informed that the country is fully advancing the pilot project of "5G + Diabetes Digital Management"
.
According to the industry, by promoting major hospitals to actively participate in the construction of the “5G + Diabetes Digital Management” project, it will be possible to upgrade the digital management of the hospital endocrinology department, improve the management level of diabetes comprehensive treatment, increase the control rate, and promote the development of disciplines and departments; innovative medical care for the hospital The new model of health service provides a new path to promote the enthusiasm of doctors to transform from traditional disease treatment to full life cycle health service
.
In recent years, the prevalence of diabetes in China has been increasing year by year, showing a younger trend.
Although new diabetes drugs have emerged in recent years, the rate of diabetes compliance and the quality of life of patients has not increased significantly.
Data show that diabetes awareness, treatment, and control rates Both are below 50%
.
In the future, as user needs continue to upgrade, digital management of diabetes will become very urgent
.